Thrombophilic mutations in high-risk atrial fibrillation patients: High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism

Daniela Poli; Emilia Antonucci; Emanuele Cecchi; Irene Betti; Lelia Valdrè; Cristina Mugnaini; Bruno Alterini; Alessandro Morettini; Carlo Nozzoli; Rosanna Abbate; Gian Franco Gensini; Domenico Prisco

Thrombophilic mutations in high-risk atrial fibrillation patients: High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism

Daniela Poli, Emilia Antonucci, Emanuele Cecchi, Irene Betti, Lelia Valdrè, Cristina Mugnaini, Bruno Alterini, Alessandro Morettini, Carlo Nozzoli, Rosanna Abbate, Gian Franco Gensini, Domenico Prisco

Fondazione Don Carlo Gnocchi Onlus

Research output: Contribution to journal › Article › peer-review

Abstract

Atrial fibrillation (AF) is a common arrhythmia that results in a high risk of cerebral and peripheral embolism. Factor V Leiden and factor II G20210A variant are two leading conditions for venous thrombosis. The aim of our study was to find out whether these two common prothrombotic mutations play a role in the occurrence of embolic events in AF patients. We investigated 336 non-valvular AF patients and 336 healthy control subjects. Factor II G20210A variant was found in 24/336 patients (7.14%) and in 11/336 of control subjects (3.3%). At a multivariate analysis, factor II G20210A variant was independently associated to AF (OR 2.4 95% CI 1.1-5.2; p

Original language	English
Pages (from-to)	1158-1162
Number of pages	5
Journal	Thrombosis and Haemostasis
Volume	90
Issue number	6
Publication status	Published - Dec 2003

Keywords

Atrial fibrillation
Factor V Leiden
Prothrombin gene
Stroke

ASJC Scopus subject areas

Hematology

Access to Document

Fingerprint Dive into the research topics of 'Thrombophilic mutations in high-risk atrial fibrillation patients: High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism'. Together they form a unique fingerprint.

Cite this

Poli, D., Antonucci, E., Cecchi, E., Betti, I., Valdrè, L., Mugnaini, C., Alterini, B., Morettini, A., Nozzoli, C., Abbate, R., Gensini, G. F., & Prisco, D. (2003). Thrombophilic mutations in high-risk atrial fibrillation patients: High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism. Thrombosis and Haemostasis, 90(6), 1158-1162.

Thrombophilic mutations in high-risk atrial fibrillation patients : High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism. / Poli, Daniela; Antonucci, Emilia; Cecchi, Emanuele; Betti, Irene; Valdrè, Lelia; Mugnaini, Cristina; Alterini, Bruno; Morettini, Alessandro; Nozzoli, Carlo; Abbate, Rosanna; Gensini, Gian Franco; Prisco, Domenico.

In: Thrombosis and Haemostasis, Vol. 90, No. 6, 12.2003, p. 1158-1162.

Research output: Contribution to journal › Article › peer-review

Poli, D, Antonucci, E, Cecchi, E, Betti, I, Valdrè, L, Mugnaini, C, Alterini, B, Morettini, A, Nozzoli, C, Abbate, R, Gensini, GF & Prisco, D 2003, 'Thrombophilic mutations in high-risk atrial fibrillation patients: High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism', Thrombosis and Haemostasis, vol. 90, no. 6, pp. 1158-1162.

Poli, Daniela ; Antonucci, Emilia ; Cecchi, Emanuele ; Betti, Irene ; Valdrè, Lelia ; Mugnaini, Cristina ; Alterini, Bruno ; Morettini, Alessandro ; Nozzoli, Carlo ; Abbate, Rosanna ; Gensini, Gian Franco ; Prisco, Domenico. / Thrombophilic mutations in high-risk atrial fibrillation patients : High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism. In: Thrombosis and Haemostasis. 2003 ; Vol. 90, No. 6. pp. 1158-1162.

@article{27aabb7e16294897a39497f061cf502c,

title = "Thrombophilic mutations in high-risk atrial fibrillation patients: High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism",

abstract = "Atrial fibrillation (AF) is a common arrhythmia that results in a high risk of cerebral and peripheral embolism. Factor V Leiden and factor II G20210A variant are two leading conditions for venous thrombosis. The aim of our study was to find out whether these two common prothrombotic mutations play a role in the occurrence of embolic events in AF patients. We investigated 336 non-valvular AF patients and 336 healthy control subjects. Factor II G20210A variant was found in 24/336 patients (7.14%) and in 11/336 of control subjects (3.3%). At a multivariate analysis, factor II G20210A variant was independently associated to AF (OR 2.4 95% CI 1.1-5.2; p",

keywords = "Atrial fibrillation, Factor V Leiden, Prothrombin gene, Stroke",

author = "Daniela Poli and Emilia Antonucci and Emanuele Cecchi and Irene Betti and Lelia Valdr{\`e} and Cristina Mugnaini and Bruno Alterini and Alessandro Morettini and Carlo Nozzoli and Rosanna Abbate and Gensini, {Gian Franco} and Domenico Prisco",

year = "2003",

month = dec,

language = "English",

volume = "90",

pages = "1158--1162",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Schattauer GmbH",

number = "6",

}

TY - JOUR

T1 - Thrombophilic mutations in high-risk atrial fibrillation patients

T2 - High prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism

AU - Poli, Daniela

AU - Antonucci, Emilia

AU - Cecchi, Emanuele

AU - Betti, Irene

AU - Valdrè, Lelia

AU - Mugnaini, Cristina

AU - Alterini, Bruno

AU - Morettini, Alessandro

AU - Nozzoli, Carlo

AU - Abbate, Rosanna

AU - Gensini, Gian Franco

AU - Prisco, Domenico

PY - 2003/12

Y1 - 2003/12

N2 - Atrial fibrillation (AF) is a common arrhythmia that results in a high risk of cerebral and peripheral embolism. Factor V Leiden and factor II G20210A variant are two leading conditions for venous thrombosis. The aim of our study was to find out whether these two common prothrombotic mutations play a role in the occurrence of embolic events in AF patients. We investigated 336 non-valvular AF patients and 336 healthy control subjects. Factor II G20210A variant was found in 24/336 patients (7.14%) and in 11/336 of control subjects (3.3%). At a multivariate analysis, factor II G20210A variant was independently associated to AF (OR 2.4 95% CI 1.1-5.2; p

AB - Atrial fibrillation (AF) is a common arrhythmia that results in a high risk of cerebral and peripheral embolism. Factor V Leiden and factor II G20210A variant are two leading conditions for venous thrombosis. The aim of our study was to find out whether these two common prothrombotic mutations play a role in the occurrence of embolic events in AF patients. We investigated 336 non-valvular AF patients and 336 healthy control subjects. Factor II G20210A variant was found in 24/336 patients (7.14%) and in 11/336 of control subjects (3.3%). At a multivariate analysis, factor II G20210A variant was independently associated to AF (OR 2.4 95% CI 1.1-5.2; p

KW - Atrial fibrillation

KW - Factor V Leiden

KW - Prothrombin gene

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0346125292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346125292&partnerID=8YFLogxK

M3 - Article

C2 - 14652651

AN - SCOPUS:0346125292

VL - 90

SP - 1158

EP - 1162

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 6

ER -